• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 1-(tert-Butyl) 5-methyl L-glutamate hydrochloride (CAS No. 34582-33-7) and Its Applications in Modern Research

1-(tert-Butyl) 5-methyl L-glutamate hydrochloride, identified by the CAS number 34582-33-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound, characterized by its hydrochloride salt form, belongs to the class of amino acid derivatives, which are widely recognized for their diverse biological activities and potential therapeutic applications. The structural modification of L-glutamate, incorporating a tert-butyl group at the alpha position and a methyl group at the fifth position, imparts unique chemical and pharmacological properties that make it a valuable candidate for further investigation.

The hydrochloride salt form of this compound enhances its solubility in aqueous solutions, facilitating its use in various experimental and industrial applications. This solubility advantage is particularly crucial in pharmaceutical formulations, where bioavailability and stability are key factors determining the efficacy of a drug. The presence of both the tert-butyl and methyl substituents not only influences the compound's physicochemical properties but also modulates its interactions with biological targets, making it a promising scaffold for drug discovery.

In recent years, there has been growing interest in amino acid derivatives as pharmacological agents due to their ability to interact with a wide range of biological targets. Among these derivatives, L-glutamate analogs have shown potential in modulating neurotransmitter systems, enzyme activities, and cellular signaling pathways. The specific structural features of 1-(tert-butyl) 5-methyl L-glutamate hydrochloride suggest that it may exhibit unique pharmacological effects compared to other glutamate derivatives. This has prompted researchers to explore its potential in various therapeutic areas, including central nervous system disorders, inflammation, and metabolic diseases.

One of the most compelling aspects of this compound is its potential role in central nervous system (CNS) research. Glutamate is an essential neurotransmitter involved in synaptic transmission and neuronal plasticity. Modulating glutamate receptor activity has been a focus of drug development efforts aimed at treating conditions such as epilepsy, depression, and neurodegenerative diseases. The structural modifications introduced in 1-(tert-butyl) 5-methyl L-glutamate hydrochloride may allow it to selectively interact with specific glutamate receptors or related signaling pathways, offering a novel approach to modulate neuronal function.

Recent studies have begun to unravel the mechanisms through which glutamate derivatives can influence CNS function. For instance, research indicates that certain amino acid analogs can modulate the activity of NMDA (N-methyl-D-aspartate) receptors, which are critically involved in synaptic plasticity and learning. The tert-butyl group in 1-(tert-butyl) 5-methyl L-glutamate hydrochloride may enhance binding affinity or alter receptor conformation, leading to altered downstream signaling events. Similarly, the methyl group could influence metabolic stability or distribution within the brain, further tailoring its pharmacological profile.

Beyond CNS applications, this compound has also shown promise in other therapeutic areas. For example, glutamate derivatives have been investigated for their anti-inflammatory properties. Excessive activation of glutamate receptors can contribute to inflammation by promoting the release of pro-inflammatory cytokines. By carefully modulating glutamate receptor activity with compounds like 1-(tert-butyl) 5-methyl L-glutamate hydrochloride, researchers aim to develop treatments that mitigate inflammation without compromising normal physiological processes.

The development of new drugs often involves rigorous testing to ensure safety and efficacy. Preclinical studies using 1-(tert-butyl) 5-methyl L-glutamate hydrochloride have begun to provide insights into its potential benefits and risks. Initial findings suggest that this compound exhibits moderate solubility and bioavailability when administered orally or intravenously. Additionally, preliminary toxicity studies indicate that it is well-tolerated at doses relevant for therapeutic use. However, further research is needed to fully characterize its pharmacokinetics and long-term safety profile.

The synthesis of 1-(tert-butyl) 5-methyl L-glutamate hydrochloride involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies have been employed to introduce the desired substituents while minimizing side reactions. Techniques such as chiral resolution and enzymatic catalysis have been particularly useful in achieving enantiopure forms of this compound, which is critical for ensuring specific biological activity.

The growing body of research on amino acid derivatives underscores their importance as therapeutic agents. As our understanding of biological systems continues to expand, compounds like 1-(tert-butyl) 5-methyl L-glutamate hydrochloride will play an increasingly significant role in drug discovery and development. Their unique structural features offer opportunities for designing molecules with tailored pharmacological properties, addressing unmet medical needs across multiple disease areas.

In conclusion,1-(tert-butyl) 5-methyl L-glutamate hydrochloride (CAS No. 34582-33-7) represents a promising candidate for further exploration in pharmaceutical research due to its unique chemical structure and potential biological activities. Its applications span multiple therapeutic areas, particularly those involving modulation of neurotransmitter systems and inflammatory processes. As ongoing studies continue to elucidate its mechanisms of action and optimize its pharmacological profile,this compound holds significant promise for future medical advancements.

• 32677-01-3(Di-tert-butyl Glutamate Hydrochloride)
• 119483-47-5(L-Norvaline t-butyl ester hydrochloride)
• 25456-76-2(H-D-Glu-OtBu)
• 2748-02-9(L-Leucine tert-butyl ester hydrochloride)
• 144313-55-3(H-Glu-otbu Hydrochloride)
• 6234-01-1(H-Glu(OtBu)-OMe hydrochloride)
• 16948-36-0((R)-5-tert-Butyl 1-methyl 2-aminopentanedioate hydrochloride)
• 15911-75-8(tert-butyl (2S)-2-aminopentanoate)
• 13081-32-8(tert-Butyl D-leucinate hydrochloride)
• 172793-31-6(H-D-Glu(otbu)-otbu hydrochloride)